Tellgen Corporation Logo

Tellgen Corporation (300642)

SZSE

Currency in CNY
16.25
-0.56 (-3.33%)

Real-time Data

01:30 AM

Day's Range

16.20
17.29

52 wk Range

11.04
30.00

Overview - 300642 - Tellgen Corporation

Key Statistics

Valuation

Enterprise Value

2.65B

P/E (Trailing)

‪167.00‬

P/E (Forward)

‪20.52‬

PEG Ratio

‪20.52‬

Price / Sales (TTM)

‪7.13‬

Price / Book

‪1.95‬

EV / EBITDA

‪36.13‬

Profitability

Gross Margin

‪64.87%‬

Profit Margin

‪3.13%‬

Operating Margin

‪14.32%‬

Return on Assets

‪0.60%‬

Return on Equity

‪0.64%‬

Ownership

Shares Outstanding

162.54M

Float

114.94M

Held by Insiders

‪33.73%‬

Held by Institutions

‪7.98%‬

Price stats

50-Day Avg

‪12.74‬

200-Day Avg

‪16.40‬

Dividends

Payout Ratio

‪152.59%‬

Frequency

Annual

News Teaser - 300642 - Tellgen Corporation

News & Analysis

View all news

Market Cap - 300642 - Tellgen Corporation

Peers - 300642 - Tellgen Corporation

Peer Comparison

Compared with companies in Medical Devices listed on SZSE.

Profile Summary - 300642 - Tellgen Corporation

About

Tellgen Corporation is a leading player in the biotechnology industry, specializing in the development and production of in vitro diagnostic products. Its primary function is to provide reliable diagnostic solutions that aid in the detection, diagnosis, and management of diseases and health conditions. Tellgen's…

SectorHealthcare
IndustryMedical Devices
Employees683
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.